Literature DB >> 26253805

Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: A 1-year, large, prospective surveillance study in 5 Italian hospitals.

Diego Delle Rose1, Pasquale Sordillo2, Sabina Gini2, Carlotta Cerva2, Stefano Boros3, Giovanni Rezza3, Marcello Meledandri4, Maria Teresa Gallo5, Grazia Prignano5, Roberta Caccese6, Mario D'Ambrosio6, Giorgia Citterio7, Monica Rocco7, Francesca Leonardis8, Silvia Natoli8, Carla Fontana9, Marco Favaro9, Maria Grazia Celeste10, Tiziana Franci11, Gian Piero Testore2, Massimo Andreoni2, Loredana Sarmati2.   

Abstract

BACKGROUND: Bloodstream infections (BSIs) from multidrug-resistant (MDR) bacteria cause morbidity and mortality in intensive care unit (ICU) patients worldwide. This study investigated the incidence of BSIs in 5 adult general ICUs in Rome, Italy, and evaluated the mortality rate and risk factors associated with these infections.
METHODS: Over a 12-month period, 1,318 patients were enrolled. Demographic characteristics, Simplified Acute Physiology Score II (SAPS II), comorbidities, and BSI isolate data were collected. After stratification for the outcome, statistical analysis was performed to assess the impact of patient risk factors on in-hospital mortality.
RESULTS: There were 324 BSIs in 175 patients recorded, with an in-hospital mortality rate of 46%. Univariate analysis revealed that SAPS II, cardiac comorbidity, and Klebsiella pneumoniae BSI were significantly associated with a higher risk of death. Having a K pneumoniae BSI and cardiac illness at admission were both confirmed to be associated with death by multivariate analysis (P = .0162 and P = .0158, respectively). Most of the K pneumoniae isolates showed high resistance rates to carbapenems.
CONCLUSION: BSIs caused by K pneumoniae and cardiovascular comorbidity in ICU patients are associated with a higher risk of death. Thorough surveillance for MDR pathogens and stratification of the patients' risk on admission into the ICU are key to improving the outcomes of these infections.
Copyright © 2015 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bloodstream infections; Intensive care unit; Klebsiella pneumoniae; Microbiology; Mortality; Predictors

Mesh:

Year:  2015        PMID: 26253805     DOI: 10.1016/j.ajic.2015.06.023

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  8 in total

1.  Optimized Use of the MALDI BioTyper System and the FilmArray BCID Panel for Direct Identification of Microbial Pathogens from Positive Blood Cultures.

Authors:  B Fiori; T D'Inzeo; A Giaquinto; G Menchinelli; F M Liotti; F de Maio; G De Angelis; G Quaranta; D Nagel; M Tumbarello; B Posteraro; M Sanguinetti; T Spanu
Journal:  J Clin Microbiol       Date:  2015-12-16       Impact factor: 5.948

2.  Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality.

Authors:  Lijun Tian; Ruoming Tan; Yang Chen; Jingyong Sun; Jialin Liu; Hongping Qu; Xiaoli Wang
Journal:  Antimicrob Resist Infect Control       Date:  2016-11-17       Impact factor: 4.887

3.  Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection.

Authors:  Zhe Wang; Ran-Ran Qin; Lei Huang; Li-Ying Sun
Journal:  Chin Med J (Engl)       Date:  2018-01-05       Impact factor: 2.628

4.  Epidemiology of carbapenem-resistant Klebsiella pneumoniae bloodstream infections after renal transplantation from donation after cardiac death in a Chinese hospital: a case series analysis.

Authors:  Yuxi Wang; Hong Lei; Yuxiang Zhang; Qiwen Yang; Yu Wang; Jiaxing Wang; Cheng Xu; Jinggang Yu; Lili Zhou; Xiaoni Kang; Lei Cui
Journal:  Antimicrob Resist Infect Control       Date:  2018-05-21       Impact factor: 4.887

5.  Incidence, Risk Factors and Clinical Outcomes of Patients with Hypermucoviscoid Klebsiella in a Tertiary Intensive Care Unit.

Authors:  Vimal Bhardwaj; Vellaichamy Muthupandi Annapandian; Annie Rofeena Sinazer; Arjun Alva; Shiva Prasad
Journal:  J Glob Infect Dis       Date:  2020-11-30

6.  Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in the intensive care unit.

Authors:  Xia Zheng; Jian-Feng Wang; Wang-Lan Xu; Jun Xu; Juan Hu
Journal:  Antimicrob Resist Infect Control       Date:  2017-10-02       Impact factor: 4.887

7.  Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.

Authors:  Yuanyuan Li; Jihong Li; Tong Hu; Jia Hu; Ning Song; Yu Zhang; Yuan Chen
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-01       Impact factor: 4.887

8.  Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial Klebsiella pneumoniae Bloodstream Infections.

Authors:  Feizhen Song; Kai Zhang; Jianjiang Huang; Zhenhua Qian; Hongwei Zhou; Jiachang Cai; Cheng Zheng; Feifei Zhou; Wei Cui; Gensheng Zhang
Journal:  Biomed Res Int       Date:  2021-06-19       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.